<Disease><Name>HYPERPHENYLALANIEMIA DUE TO GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE DEFICIENCY</Name><Synonym>GTP CYCLOHYDROLASE I DEFICIENCY; GTPCH DEFICIENCY</Synonym><OMIM><Number>233910</Number><URL>http://omim.org/entry/233910</URL></OMIM><Orphanet><Number>2102</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=2102</URL></Orphanet><Protein><Number>GTP cyclohydrolase 1</Number><URL>http://www.uniprot.org/uniprot/P30793</URL></Protein><ExPASy><Number>3.5.4.16</Number><URL>http://enzyme.expasy.org/EC/3.5.4.16</URL></ExPASy><Gene>14q22.2</Gene><ICD>E70.1</ICD><Summary>rare (&lt;1:1000000);autosomal recessive ;mutations in the ;guanosine triphosphate; ;cyclohydrolase; 1 (GCH1) gene;BH4- or combined BH4-phenylalanine loading test abnormal</Summary><Symptoms><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2537</id><symptom>hyperthermia</symptom><category>ENDOCRINE SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1652</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>3.50</min><max>11.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1781</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1837</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1961</id><name>Phenylalanine</name><specimen>blood</specimen><value>decreased</value><min>0.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1962</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>34.00</min><max>86.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2089</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2090</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>424</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>425</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>426</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>934</id><name>Biopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>10.00</min><max>50.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>933</id><name>Guanosine triphosphate cyclohydrolase</name><specimen>liver</specimen><value>decreased</value><min>    </min><max>100.00</max><unit>% activity</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1919</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>422</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1054</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>423</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>427</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>935</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>9.00</min><max>20.00</max><unit>nmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1055</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>9.00</min><max>40.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>1548</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>5.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>156</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>4.00</min><max>32.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>871</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>6.00</min><max>31.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1513</id><name>Phenylalanine</name><specimen>urine</specimen><value>normal/inc</value><min>7.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>52</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>21.00</min><max>137.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>930</id><name>Phenylalanine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1057</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>35.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1294</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1295</id><name>Phenylalanine</name><specimen>plasma</specimen><value>increased</value><min>26.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite></Metabolites><Literatures><literature><id>5996</id><title>[Autosomal recessive GTPCH 1 deficiency: the importance of the analysis of neurotransmitters in cerebrospinal fluid]</title><author>Moreno-Medinilla EE,</author><journal>Rev Neurol</journal><year>2016</year><book /><volume>62</volume><number>11</number><pages>502-506</pages><co_aut>et al.</co_aut></literature><literature><id>5997</id><title>Growth hormone deficiency in a dopa-responsive dystonia patient with a novel mutation of guanosine triphosphate cyclohydrolase </title><author>Lin Y,</author><journal>J Child Neurol</journal><year>2015</year><book /><volume>30</volume><number>6</number><pages>796-799</pages><co_aut>et al.</co_aut></literature><literature><id>5998</id><title>Early replacement therapy in a first Japanese case with autosomal recessive guanosine triphosphate cyclohydrolase I deficiency </title><author>Sato H,</author><journal>Brain Dev</journal><year>2014</year><book /><volume>36</volume><number>3</number><pages>268-271</pages><co_aut>et al.</co_aut></literature><literature><id>5999</id><title>GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour</title><author>Pan L,</author><journal>BMJ Case Rep</journal><year>2011</year><book /><volume>2011</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6000</id><title>Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I de</title><author>Opladen T,</author><journal>Mov Disord</journal><year>2011</year><book /><volume>26</volume><number>1</number><pages>157-161</pages><co_aut>et al.</co_aut></literature><literature><id>6001</id><title>Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between d</title><author>Horvath GA,</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>94</volume><number>1</number><pages>127-131</pages><co_aut>et al.</co_aut></literature><literature><id>2432</id><title>Tetrahydrobiopterin in pulmonary hypertension: pulmonary hypertension in guanosine triphosphate-cyclohydrolase-deficient mice&lt;/</title><author>Pritchard KA Jr</author><journal>Circulation</journal><year>2005</year><book /><volume>111</volume><number>16</number><pages>2022-2024</pages><co_aut>Shi Y, Konduri GG</co_aut></literature><literature><id>1085</id><title>Molecular genetics of dopa-responsive dystonia</title><author>Ichinose H</author><journal>Biol Chem</journal><year>1999</year><book /><volume>380</volume><number>0</number><pages>1355-1364</pages><co_aut>et al.</co_aut></literature><literature><id>365</id><title>International database of tetrahydrobiopterin deficiencies</title><author>Blau N</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>8-14</pages><co_aut>Barnes I, Dhondt JL</co_aut></literature><literature><id>1008</id><title>Hyperphenylalaninemia</title><author>Blau N</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>65-78</pages><co_aut>Blaskovics ME</co_aut></literature><literature><id>113</id><title>The hyperphenylalaninemias</title><author>Scriver CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1015-1075</pages><co_aut>et al.</co_aut></literature><literature><id>263</id><title>A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program</title><author>Blau N</author><journal>J Pediatr</journal><year>1995</year><book /><volume>126</volume><number>3</number><pages>401-405</pages><co_aut>et al.</co_aut></literature><literature><id>691</id><title>GTP cyclohydrolase I gene in hereditary progressive dystonia with diurnal fluctuation</title><author>Ichinose H</author><journal>Neurosci Lett</journal><year>1995</year><book /><volume>196</volume><number>0</number><pages>5-8</pages><co_aut>et al.</co_aut></literature><literature><id>264</id><title>Combined phenylalanine-tetrahydrobiopterin loading test in GTP cyclohydrolase I deficiency</title><author>Ponzone A</author><journal>Eur J Pediatr</journal><year>1994</year><book /><volume>153</volume><number>8</number><pages>616</pages><co_aut>et al.</co_aut></literature><literature><id>875</id><title>Guanosine triphosphate cyclohydrolase I deficiency: Early diagnosis by routine urine pteridine screening</title><author>Naylor EW</author><journal>Pediatrics</journal><year>1987</year><book /><volume>79</volume><number>0</number><pages>374-</pages><co_aut>et al.</co_aut></literature><literature><id>273</id><title>Neonatal hyperphenylalaninemia presumably caused by guanosine triphosphate-cyclohydrolase deficiency</title><author>Dhondt JL</author><journal>J Pediatr</journal><year>1985</year><book /><volume>106</volume><number>0</number><pages>954-956</pages><co_aut>et al.</co_aut></literature><literature><id>272</id><title>GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and sero</title><author>Niederwieser A</author><journal>Eur J Pediatr</journal><year>1984</year><book /><volume>141</volume><number>0</number><pages>208-214</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>